Cedilla Therapeutics Raises $56M in Series A Funding

Retrieved on: 2018-04-23 23:00:00

Tags for this article:

Medicine

Third Rock Ventures

Awards

William Kaelin Jr.

Science and technology awards

Ed Harlow

Click the tags to see associated articles and topics

Cedilla Therapeutics Raises $56M in Series A Funding. View article details on hiswai:

Excerpt

<div>Cedilla Therapeutics, a Cambridge, MA-based biotechnology company, raised $56.2m in Series A funding. <b>Third Rock Ventures</b> made the investment. Launched in 2018 by <b>Third Rock Ventures</b> and by Alexandra Glucksmann, Ph.D., president and chief executive officer, by Brian Jones, Ph.D., chief ...</div>

Article found on:

View Original Article